Study confirms findings of the Transparaa?? by ScreenPoint Medical AI mammogram decision support system

LONDON, Jan. 3, 2020 /PRNewswire-PRWeb/ --A ScreenPoint Medical's Scientists who developed the Transpara AI decision support system which helps radiologists to identify potential breast cancers earlier and faster, say a new international study by Google Health and Imperial College, London, supports the findings of radiologists already using the Transpara system in 15 countries, including Hungary, Turkey, the USA and France.The new study, published in the journal Nature, showed that AI could perform at least as well or better than specialist breast radiologists.The incidence of breast cancer is increasing worldwide due to environmental, diet and lifestyle changes but increasingly, countries are reporting a shortage of radiologists. In the UK and some other countries, every mammogram is read by two specialist radiologists. However, this is expensive and elsewhere often radiologists work alone. In the US for example, 60% of radiologists reading mammograms are general radiologists. It is believed that overall up to 25% of breast cancers are missed but the earlier a cancer is discovered and the earlier a patient can be treated, the greater the chance that she will survive the cancer."As academics we set out to try and reduce the death toll from breast cancer, to help radiologists work more efficiently and also to reduce the number of women who were being needlessly recalled for often invasive and painful treatments," said Professor Prof Nico Karssemeijer CEO and co-founder of ScreenPoint Medical, the company that produces the Transpara system.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2020    »